相似文献
1
Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?
Cancer Biol Med. 2016 Jun;13(2):206-14. doi: 10.20892/j.issn.2095-3941.2015.0070.
2
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10857-62. doi: 10.1073/pnas.191117498.
3
Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis.
Mol Med. 2006 Jul-Aug;12(7-8):127-36. doi: 10.2119/2006-00024.Man.
4
Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways.
Biochem Biophys Res Commun. 2005 Aug 19;334(1):193-198. doi: 10.1016/j.bbrc.2005.06.065.
5
An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells.
Int J Oncol. 2005 Dec;27(6):1625-32.
6
Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg. 2003 Aug;129(8):882-8. doi: 10.1001/archotol.129.8.882.
7
Role of hypoxia in inhibiting dendritic cells by VEGF signaling in tumor microenvironments: mechanism and application.
Am J Cancer Res. 2021 Aug 15;11(8):3777-3793. eCollection 2021.
8
Gene expression profile of vascular endothelial growth factor (VEGF) and its receptors in various cell types of the canine lymph node using laser capture microdissection (LCM).
Vet Immunol Immunopathol. 2011 Apr 15;140(3-4):207-14. doi: 10.1016/j.vetimm.2010.12.005. Epub 2010 Dec 15.
9
Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Angiogenesis. 2005;8(3):197-204. doi: 10.1007/s10456-005-9010-0. Epub 2005 Nov 19.
10
Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
Int J Oncol. 2008 Mar;32(3):585-92.
引用本文的文献
1
Cytokine Networks in Triple-Negative Breast Cancer: Mechanisms, Therapeutic Targets, and Emerging Strategies.
Biomedicines. 2025 Aug 8;13(8):1945. doi: 10.3390/biomedicines13081945.
2
Long-term DNA methylation changes mediate heterologous cytokine responses after BCG vaccination.
Genome Biol. 2025 Jul 9;26(1):180. doi: 10.1186/s13059-025-03611-9.
3
The expression and relationship of VEGF and MVD in type I endometrial cancer.
Medicine (Baltimore). 2025 Jun 27;104(26):e42945. doi: 10.1097/MD.0000000000042945.
4
AI-Driven Multiscale Study on the Mechanism of Polygonati Rhizoma in Regulating Immune Function in STAD.
ACS Omega. 2025 May 11;10(19):19770-19796. doi: 10.1021/acsomega.5c00981. eCollection 2025 May 20.
5
Development and Validation of an Extracellular Matrix Gene Expression Signature for Prognostic Prediction in Patients with Uveal Melanoma.
Int J Mol Sci. 2025 May 1;26(9):4317. doi: 10.3390/ijms26094317.
6
Natural Products as Novel Therapeutic Agents for Triple-Negative Breast Cancer: Current Evidence, Mechanisms, Challenges, and Opportunities.
Molecules. 2025 Mar 7;30(6):1201. doi: 10.3390/molecules30061201.
7
Vascular endothelial growth factor A: friend or foe in the pathogenesis of HIV and SARS-CoV-2 infections?
Front Cell Infect Microbiol. 2025 Feb 11;14:1458195. doi: 10.3389/fcimb.2024.1458195. eCollection 2024.
8
EZH2 elicits CD8 T-cell desert in esophageal squamous cell carcinoma via suppressing CXCL9 and dendritic cells.
Commun Biol. 2024 Dec 19;7(1):1645. doi: 10.1038/s42003-024-07341-9.
9
Dual role of vascular endothelial growth factor-C in post-stroke recovery.
J Exp Med. 2025 Feb 3;222(2). doi: 10.1084/jem.20231816. Epub 2024 Dec 12.
10
MACC1 revisited - an in-depth review of a master of metastasis.
Biomark Res. 2024 Nov 23;12(1):146. doi: 10.1186/s40364-024-00689-4.
本文引用的文献
1
Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signaling and protects against endotoxin shock.
Immunity. 2014 Apr 17;40(4):501-14. doi: 10.1016/j.immuni.2014.01.013. Epub 2014 Mar 20.
2
HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
Carcinogenesis. 2013 Aug;34(8):1699-707. doi: 10.1093/carcin/bgt209. Epub 2013 Jun 5.
3
Macrophage biology in development, homeostasis and disease.
Nature. 2013 Apr 25;496(7446):445-55. doi: 10.1038/nature12034.
4
Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.
Blood. 2013 May 16;121(20):4242-9. doi: 10.1182/blood-2012-08-453043. Epub 2013 Mar 8.
5
Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients.
PLoS One. 2013;8(2):e56836. doi: 10.1371/journal.pone.0056836. Epub 2013 Feb 13.
6
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2.
Br J Cancer. 2012 Nov 20;107(11):1869-75. doi: 10.1038/bjc.2012.468.
7
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.
J Exp Med. 2012 Oct 22;209(11):2001-16. doi: 10.1084/jem.20111497. Epub 2012 Oct 8.
8
Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.
Am J Pathol. 2012 Nov;181(5):1607-20. doi: 10.1016/j.ajpath.2012.07.021. Epub 2012 Sep 7.
9
Signal transduction by vascular endothelial growth factor receptors.
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006502. doi: 10.1101/cshperspect.a006502.
10
Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment.
Cancer Res. 2012 Aug 15;72(16):4047-59. doi: 10.1158/0008-5472.CAN-11-3907. Epub 2012 Jun 27.
Zotero 插件